A Nasal Treatment for COVID-19

NCT05799521 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

COVID-19
Healthy

Interventions

DRUG: Optate
DRUG: Placebo

Sponsor

Indiana University